On Wednesday, the U.S. Centers for Disease Control and Prevention said that the number of infected people from the E.coli
1 year ago
AstraZeneca’s (NASDAQ: AZN) China president is under investigation and is cooperating with Chinese authorities, the company said on Wednesday, sending
On Wednesday, GSK (NYSE: GSK) said its vaccine sales would fall this year, after a weaker-than-expected performance for its respiratory
FRANKFURT – Novartis, the Swiss drugmaker, raised its 2024 earnings guidance on Tuesday for the third time buoyed by wider
Novartis (NYSE: NVS), the Swiss pharmaceutical giant, will pay Monte Rosa Therapeutics (NASDAQ: GLUE) $150 million upfront payment for a
On Friday, Sanofi (NASDAQ: SNY), the French drug maker, posted stronger earnings growth than analysts had expected in the third
The February hack at UnitedHealth’s (NYSE: UNH) tech unit Change affected the personal information of 100 million people, the U.S.
FRANKFURT – The CEO of pharmaceuticals giant Roche said authorities should block the takeover of contract drug manufacturer Catalent (NYSE:
NEW YORK – Most U.S. states do not currently cover highly sought-after weight-loss drugs from Novo Nordisk (NYSE: NVO) and
Did you know that the worldwide biotechnology industry is expected to increase at a CAGR of 13.96% from 2024 to
On Monday, Novo Nordisk (NYSE: NVO) said an oral version of its drug semaglutide, helped significantly reduce the risk of
On Monday, Catalent (NYSE: CTLT) CEO Alessandro Maselli said he will remain at the helm of the U.S.-based contract drugmaker
